$1.73 Billion is the total value of Vivo Capital, LLC's 64 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 37.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ASND | ASCENDIS PHARMA A/Ssponsored adr | $277,428,000 | +4.3% | 1,797,745 | 0.0% | 16.03% | -15.9% | |
| ALXO | New | ALX ONCOLOGY HLDGS INC | $159,265,000 | – | 4,220,048 | +100.0% | 9.20% | – |
| HRMY | New | HARMONY BIOSCIENCES HLDGS IN | $153,714,000 | – | 4,534,341 | +100.0% | 8.88% | – |
| NFH | NEW FRONTIER HEALTH CORP | $109,109,000 | -7.9% | 14,300,000 | 0.0% | 6.30% | -25.7% | |
| LEGN | Sell | LEGEND BIOTECH CORPsponsored ads | $102,805,000 | -32.1% | 3,330,269 | -6.3% | 5.94% | -45.2% |
| GTH | GENETRON HLDGS LTDads | $75,698,000 | -1.1% | 6,339,860 | 0.0% | 4.38% | -20.3% | |
| AMRS | Buy | AMYRIS INC | $38,424,000 | -11.6% | 13,158,914 | +29.2% | 2.22% | -28.7% |
| SVA | SINOVAC BIOTECH LTD | $38,173,000 | 0.0% | 5,900,000 | 0.0% | 2.21% | -19.4% | |
| IMVT | Buy | IMMUNOVANT INC | $36,684,000 | +88.3% | 1,042,460 | +30.3% | 2.12% | +51.8% |
| CRNX | Sell | CRINETICS PHARMACEUTICALS IN | $35,473,000 | -12.6% | 2,263,770 | -2.3% | 2.05% | -29.6% |
| ISEE | IVERIC BIO INC | $33,651,000 | +10.6% | 5,966,527 | 0.0% | 1.94% | -10.9% | |
| ARQT | Sell | ARCUTIS BIOTHERAPEUTICS INC | $32,619,000 | -16.3% | 1,113,265 | -13.7% | 1.88% | -32.6% |
| KURA | KURA ONCOLOGY INC | $32,172,000 | +88.0% | 1,050,000 | 0.0% | 1.86% | +51.5% | |
| ZYME | Sell | ZYMEWORKS INC | $29,830,000 | +12.6% | 640,411 | -12.8% | 1.72% | -9.2% |
| PASG | Sell | PASSAGE BIO INC | $28,730,000 | -52.9% | 2,191,453 | -1.7% | 1.66% | -62.0% |
| CLDX | Buy | CELLDEX THERAPEUTICS INC NEW | $25,545,000 | +22.8% | 1,722,500 | +7.7% | 1.48% | -1.0% |
| ARWR | ARROWHEAD PHARMACEUTICALS IN | $24,824,000 | -0.3% | 576,505 | 0.0% | 1.44% | -19.6% | |
| SAGE | Buy | SAGE THERAPEUTICS INC | $21,607,000 | +51.4% | 353,511 | +3.0% | 1.25% | +22.1% |
| MYOK | MYOKARDIA INC | $21,582,000 | +41.1% | 158,310 | 0.0% | 1.25% | +13.7% | |
| KDMN | Sell | KADMON HLDGS INC | $20,742,000 | -24.2% | 5,291,336 | -1.1% | 1.20% | -38.9% |
| SRRA | New | SIERRA ONCOLOGY INC | $20,455,000 | – | 1,917,074 | +100.0% | 1.18% | – |
| RCKT | ROCKET PHARMACEUTICALS INC | $19,674,000 | +9.2% | 860,648 | 0.0% | 1.14% | -12.0% | |
| VRNA | Buy | VERONA PHARMA PLCsponsored ads | $19,023,000 | +172.3% | 3,048,507 | +104.2% | 1.10% | +119.4% |
| KALV | KALVISTA PHARMACEUTICALS INC | $18,593,000 | +4.1% | 1,476,796 | 0.0% | 1.07% | -16.2% | |
| NVAX | New | NOVAVAX INC | $17,791,000 | – | 164,199 | +100.0% | 1.03% | – |
| AVDL | AVADEL PHARMACEUTICALS PLCsponsored adr | $17,772,000 | -37.6% | 3,526,093 | 0.0% | 1.03% | -49.7% | |
| KNSA | KINIKSA PHARMACEUTICALS LTD | $17,643,000 | -39.9% | 1,151,622 | 0.0% | 1.02% | -51.5% | |
| AKRO | Sell | AKERO THERAPEUTICS INC | $17,607,000 | +19.5% | 571,833 | -3.3% | 1.02% | -3.6% |
| CDXS | Sell | CODEXIS INC | $17,332,000 | +1.8% | 1,476,289 | -1.2% | 1.00% | -17.9% |
| MREO | Buy | MEREO BIOPHARMA GROUP PLCads | $16,299,000 | +584.5% | 6,220,938 | +699.6% | 0.94% | +450.9% |
| NKTX | New | NKARTA INC | $15,397,000 | – | 512,225 | +100.0% | 0.89% | – |
| CYTK | New | CYTOKINETICS INC | $15,155,000 | – | 700,000 | +100.0% | 0.88% | – |
| CBAY | CYMABAY THERAPEUTICS INC | $15,127,000 | +107.4% | 2,089,356 | 0.0% | 0.87% | +67.1% | |
| ZGNX | Buy | ZOGENIX INC | $14,666,000 | -17.5% | 817,935 | +24.2% | 0.85% | -33.5% |
| EIGR | EIGER BIOPHARMACEUTICALS INC | $14,581,000 | -15.2% | 1,791,257 | 0.0% | 0.84% | -31.6% | |
| CALT | CALLIDITAS THERAPEUTICS ABsponsored ads | $13,920,000 | +3.4% | 580,000 | 0.0% | 0.80% | -16.7% | |
| ADRO | ADURO BIOTECH INC | $12,438,000 | +5.2% | 5,118,560 | 0.0% | 0.72% | -15.2% | |
| LRMR | LARIMAR THERAPEUTICS INC | $12,131,000 | +18.1% | 799,662 | 0.0% | 0.70% | -4.9% | |
| EPIX | New | ESSA PHARMA INC | $10,466,000 | – | 1,516,865 | +100.0% | 0.60% | – |
| ZLAB | ZAI LAB LTDadr | $10,156,000 | +1.3% | 122,107 | 0.0% | 0.59% | -18.4% | |
| FIXX | Sell | HOMOLOGY MEDICINES INC | $9,129,000 | -31.4% | 853,143 | -2.6% | 0.53% | -44.7% |
| MTNB | MATINAS BIOPHARMA HLDGS INC | $8,640,000 | -0.9% | 11,279,323 | 0.0% | 0.50% | -20.2% | |
| PSTX | New | POSEIDA THERAPEUTICS INC | $8,218,000 | – | 926,449 | +100.0% | 0.48% | – |
| CVAC | New | CUREVAC N V | $7,905,000 | – | 169,825 | +100.0% | 0.46% | – |
| IGMS | Sell | IGM BIOSCIENCES INC | $7,638,000 | -12.4% | 103,480 | -13.4% | 0.44% | -29.4% |
| AUPH | AURINIA PHARMACEUTICALS INC | $7,376,000 | -9.4% | 500,732 | 0.0% | 0.43% | -26.9% | |
| OVID | New | OVID THERAPEUTICS INC | $7,175,000 | – | 1,250,000 | +100.0% | 0.42% | – |
| DYN | New | DYNE THERAPEUTICS INC | $6,360,000 | – | 315,000 | +100.0% | 0.37% | – |
| KALA | KALA PHARMACEUTICALS INC | $5,902,000 | -28.6% | 786,883 | 0.0% | 0.34% | -42.5% | |
| ATHA | New | ATHIRA PHARMA INC | $5,538,000 | – | 300,000 | +100.0% | 0.32% | – |
| ORTX | ORCHARD THERAPEUTICS PLCads | $5,449,000 | -31.5% | 1,325,736 | 0.0% | 0.32% | -44.7% | |
| ETNB | New | 89BIO INC | $4,697,000 | – | 183,042 | +100.0% | 0.27% | – |
| BDTX | Sell | BLACK DIAMOND THERAPEUTICS I | $4,396,000 | -30.7% | 145,417 | -3.3% | 0.25% | -44.2% |
| ACRS | ACLARIS THERAPEUTICS INC | $4,233,000 | +58.7% | 1,647,214 | 0.0% | 0.24% | +28.3% | |
| RVMD | Sell | REVOLUTION MEDICINES INC | $3,463,000 | -45.0% | 99,517 | -50.1% | 0.20% | -55.8% |
| VYNE | New | VYNE THERAPEUTICS INC | $3,024,000 | – | 1,821,912 | +100.0% | 0.18% | – |
| CNST | CONSTELLATION PHARMCETICLS I | $2,842,000 | -32.6% | 140,298 | 0.0% | 0.16% | -45.7% | |
| AVRO | Sell | AVROBIO INC | $2,685,000 | -39.3% | 206,225 | -18.7% | 0.16% | -51.1% |
| ATRC | ATRICURE INC | $2,576,000 | -11.3% | 64,573 | 0.0% | 0.15% | -28.4% | |
| MEIP | Sell | MEI PHARMA INC | $2,549,000 | -43.0% | 816,956 | -24.5% | 0.15% | -54.1% |
| SELB | Sell | SELECTA BIOSCIENCES INC | $2,349,000 | -63.3% | 947,175 | -58.0% | 0.14% | -70.4% |
| TCDA | Sell | TRICIDA INC | $1,583,000 | -67.0% | 174,763 | -0.0% | 0.09% | -73.5% |
| MTCR | New | METACRINE INC | $1,495,000 | – | 146,426 | +100.0% | 0.09% | – |
| DTIL | PRECISION BIOSCIENCES INC | $864,000 | -26.0% | 140,255 | 0.0% | 0.05% | -40.5% | |
| DBVT | Exit | DBV Technologies S.A.adr | $0 | – | -269,995 | -100.0% | -0.08% | – |
| GLMD | Exit | Galmed Pharmaceuticals Ltd | $0 | – | -860,103 | -100.0% | -0.30% | – |
| MNLO | Exit | Menlo Therapeutics Inc. | $0 | – | -3,643,824 | -100.0% | -0.45% | – |
| VSTM | Exit | Verastem Inc | $0 | – | -4,639,535 | -100.0% | -0.57% | – |
| SRRA | Exit | Sierra Oncology, Inc | $0 | – | -1,917,074 | -100.0% | -1.66% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-11-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ACLARIS THERAPEUTICS INC | 29 | Q3 2023 | 33.5% |
| CODEXIS INC | 29 | Q3 2023 | 8.0% |
| ASCENDIS PHARMA A/S | 25 | Q3 2022 | 24.0% |
| KALVISTA PHARMACEUTICALS INC | 25 | Q3 2023 | 3.9% |
| Verona Pharma PLC ADR | 24 | Q3 2023 | 7.6% |
| AMYRIS INC | 23 | Q3 2023 | 8.8% |
| EIGER BIOPHARMACEUTICALS INC | 23 | Q1 2022 | 8.7% |
| Zai Lab Ltd ADR | 22 | Q3 2023 | 1.8% |
| Arrowhead Pharmaceuticals Inc | 21 | Q3 2023 | 6.9% |
| HOMOLOGY MEDICINES INC | 21 | Q3 2023 | 3.7% |
View Vivo Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| SINOVAC BIOTECH LTDSold out | August 27, 2018 | 0 | 0.0% |
View Vivo Capital, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-22 |
| 13F-HR | 2024-02-07 |
| 13F-HR | 2023-11-08 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-11 |
View Vivo Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.